Johnson & Johnson Pa
Contact Information
Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program
P.O. Box 221857
Charlotte, NC 28222-1857
1-(800) 652-6227 (phone)
1-(888) 526-5168 (fax)
Physician requests should be directed to:
Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program
P.O. Box 221857
Charlotte, NC
28222-1857
1-(800) 652-6227 (phone)
Eligibility:
Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)* is committed to helping you get the prescription medications you need. If you qualify, the Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program* makes it easier for you to receive free medications manufactured by the Operating Companies of Johnson & Johnson.
Other Information:
*Independent
program not owned or operated by the Operating Companies of Johnson & Johnson
Product(s) covered by program:
- Aciphex®
- Alamast®
- Axert®
- Betimol®
- Biafine®
- Concerta® Extended-Release Tablets CII
- Ditropan® XL Extended Release Tablets
- DOXIL® (doxorubicin HCl liposome injection)
- Duragesic® (fentanyl transdermal system) CII
- EDURANT™ (rilpivirne) Tablets
- Elmiron®
- Ertaczo™ Cream 2%
- Flexeril® Tablets
- Grifulvin-V® microsize Tablets
- Haldol® Decanoate Injection
- Haldol® Injection
- INTELENCE™ (etravirine) Tablets
- INVEGA® (paliperidone) Extended-Release Tablets
- INVEGA® SUSTENNA™ (paliperidone palmitate) Extended-Release Injectable Suspension
- IQUIX®
- LEUSTATIN® (cladribine) Injection
- Levaquin®
- Natrecor®
- NUCYNTA™ (tapentadol) immidiate-release oral tablets C-II
- ORTHOVISC
- Pancrease® MT Capsules
- Parafon Forte® DSC (chlorazoxazone) Caplets
- PREZISTA® (darunavir) Tablets
- PROCRIT® (Epoetin alfa) FOR INJECTION
- Quixin®
- Razadyne™ (galantamine HBr) Tablets & Oral Solution
- Razadyne™ ER (galantamine HBr) Extended-Release Capsules
- REMICADE® (infliximab) for IV Injection
- Risperdal Consta® Long-Acting Injection
- Risperdal® M-TAB®
- Risperdal® Tablets and Oral Solution
- SIMPONI™ (golimumab)
- Sporanox® (itraconazole) Capsules & Oral Solution
- STELARA™ (ustekinumab)
- Terazol® 3 Vaginal Suppositories
- Terazol® 7 Vaginal Cream
- Topamax® (topiramate capsules) Sprinkle Capsules
- Topamax® (topiramate) Tablets
- Ultracet® (tramadol hydrochloride/acetaminophen tablets)
- Ultram® (tramadol HCL tablets)
- Ultram® ER (tramadol HCL) Extended-Release Tablets
- Uvadex® (Methoxsalen) STERILE SOLUTION
- XARELTO® (rivoroxaban tablets)
- ZYTIGA™ (abiraterone acetate) Tablets
Thanks for visiting! GoodRx is not available outside of the United States. If you are trying to access this site from the United States and believe you have received this message in error, please reach out to and let us know.
Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis. | |
Program 1 of 3. Scroll down to see them all. | Back | Print| Print All |
| |
Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance ProgramThis program provides medication at no cost. | |
Provided by: Johnson & Johnson Patient Assistance Foundation, Inc. | |
PO Box 0367 TEL: 800-652-6227FAX: 888-526-5168 | Languages Spoken: English, Spanish, Others By Translation Service Program Website |
Program Applications and Forms | |
Johnson & Johnson Patient Assistance Foundation, Inc. Patient Application | |
HIV Common Application: Johnson & Johnson Patient Assistance Foundation, Inc. | |
Medications | |
| |
Eligibility Requirements
| |
Insurance Status | Must have no prescription coverage for needed medication |
Those with Part D Eligible? | *See Additional Information Section Below |
Income | Varies. **See below for details |
Diagnosis/Medical Criteria | Medication must be for outpatient use only |
US Residency Required? | Must reside permanently in the US or US territories |
Application | |
Obtaining | Call or download |
Receiving | Faxed, mailed or downloaded from website |
Returning | Fax or mail |
Doctor's Action | Complete section and sign |
Applicant's Action | Complete section, sign, attach required documents |
Decision Communicated | Patient and Doctor are notified |
Decision Timeframe | 3-5 business days |
Medication | |
Amount/Supply | Not specified |
Sent To | Doctor's office or patient is sent card to be used at pharmacy |
Delivery Time | Varies |
Refill Process | Varies per medication |
Limit | Varies |
Re-application | New application, new documentation yearly |
Additional Information | |
*Some Medicare Part D patients who cannot afford their medicines, and who meet certain financial criteria, may also be eligible for assistance. Please Contact the program for more information (1-800-652-6227). **Please call 1-800-652-6227 or visit Program website for specific FPL income requirements. | |
Updated October 03, 2022 |
Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis. | |
Program 2 of 3. Scroll down to see them all. | Back | Print| Print All |
| |
Janssen CarePathThis program provides brand name medications at no or low cost | |
Provided by: Janssen | |
TEL: 877-227-3728 | Languages Spoken: English, Spanish, Others By Translation Service Program Website |
Program Applications and Forms | |
Janssen CarePath Online Enrollment | |
Medications | |
| |
Eligibility Requirements
| |
Insurance Status | Determined case by case |
Those with Part D Eligible? | Varies |
Income | Based on FPL |
Diagnosis/Medical Criteria | Must be used for on-label diagnosis |
US Residency Required? | Must be citizen or legal resident |
Application | |
Obtaining | Applicant must call for prescreening |
Receiving | Patient is contacted if eligible after phone screening |
Returning | Varies |
Doctor's Action | Complete section, sign, attach required documents |
Applicant's Action | Call for information or inform doctor that he/she is in need |
Decision Communicated | Patient and Doctor are notified |
Decision Timeframe | Varies |
Medication | |
Amount/Supply | Varies |
Sent To | Varies |
Delivery Time | Varies |
Refill Process | Patient or Doctor must contact company |
Limit | Not specified |
Re-application | New application, new documentation yearly |
Additional Information | |
Call for most recent medications as the list is subject to change. | |
Updated October 27, 2022 |
Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis. | |
Program 3 of 3. | Back | Print| Print All |
| |
Patient Access Network Foundation (PAN)This is a copay assistance program | |
Provided by: Patient Access Network Foundation | |
TEL: 866-316-7263FAX: 866-316-7261 | Languages Spoken: English, Spanish, Others By Translation Service Program Website |
Program Applications and Forms | |
Patient Access Network Foundation (PAN) Application: Contact program | |
Medications | |
| |
Eligibility Requirements
| |
Insurance Status | *See Additional Information section below |
Those with Part D Eligible? | Determined case by case |
Income | Between 400-500% of FPL |
Diagnosis/Medical Criteria | FDA Approved Diagnosis - See Program Website for Details |
US Residency Required? | Must reside and receive treatment in US |
Application | |
Obtaining | Call or complete online |
Receiving | Complete online or by phone |
Returning | Not applicable |
Doctor's Action | Varies |
Applicant's Action | Call for information or inform doctor that he/she is in need |
Decision Communicated | Patient and Doctor are notified |
Decision Timeframe | Within 48 hours |
Medication | |
Amount/Supply | Not applicable |
Sent To | Patient is sent savings card to be used at pharmacy |
Delivery Time | Once approved; shipped same day |
Refill Process | Patient presents voucher/card to pharmacy for each refill |
Limit | None |
Re-application | New application every 12 months |
Additional Information | |
*Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details. | |
Updated November 07, 2022 |